Metabolic dynamics and stage-specific biomarkers in chronic HBV infection: a metabolomics study

Hepatitis

EASL 2025 indications revisited: phase-specific outcomes with and without nucleos(t)ide analogue therapy in chronic hepatitis B virus infection

Gut

Tang S, Huang T, Tang R, Lin K, Luo C, Shen Y, Zhang K, Tang Y, Kong J, Chen Z, Fu J, Lin Q, Guo L, Wu Y, Li Y, Zhang J, Sun Z, You P, Zhang D, Chen Y, Lin X, Zhong C, Lin Z, Liu H, Huang Z, Zhou W, Dong P, Liu X, Zeng H, Qi X, Zeng Y

doi: 10.1136/gutjnl-2025-335449

Further Publications

Association of liver related biomarkers with incident cardiovascular disease and all-cause mortality in the Hispanic community health study/study of Latinos (HCHS/SOL), a population-based cohort study

BMC Gastroenterol

Trejo MJ, Floyd JS, Massera D, Daviglus M, Garcia-Bedoya O, Cai J, Talavera GA, Tamayo-Murillo DE, Labovitz D, Kaplan R

doi: 10.1186/s12876-025-04133-1

HepatitisHepatology

Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologies

Gut

Luo J, Hu M, Feng T, Zhang L, Huang Y, Huang Y, Ye F, Li J, Aguilar F, Sánchez-Garrido C, Usón-Raposo E, Zhu B, Zhou Q, Liang X, Li J, Li P, Xin J, Shi D, Zheng J, Zhang H, Wang B, Qiang W, Yao H, Zhou X, Chen J, Hu W, Li B, Ma S, Wu X, Li X, Kong Y, Sun F, Chen X, Wu T, Yang L, Sun S, Guo B, He L, Chen J, Xin S, Li X, Chen H, Angeli P, Jalan R, Lin B, Chen Y, You S, Chen X, Queiroz Farias A, Trebicka J, Jiang J, Moreau R, Li J, CANONIC, PREDICT, ACLARA Study Group, Chinese Group on the Study of Severe Hepatitis B (COSSH)

doi: 10.1136/gutjnl-2025-335651

Hepatitis

Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial

Gut

Wu X, Quan D, Li W, Wisskirchen K, Wu W, Zhou Y, Liu YP, Wan X, Wang X, Zhang X, Yang L, Zheng M, Zhang K, Protzer U, Du S, Qu X

doi: 10.1136/gutjnl-2025-335456

Hepatology

Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study : MASLD, MetALD, and dementia risk

BMC Gastroenterol

Shin WY, Kang ES, Oh YH, Sha M, Xia Q, Jeong S, Cho Y

doi: 10.1186/s12876-025-03814-1

HepatitisHepatology

Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phases

J Hepatol

Le Bert N, Koffas A, Kumar R, Facchetti F, Tan AT, Gill US, Mak LY, Stretch SW, Miao T, Hariharaputran S, Hang SK, Guo Y, Chen Q, Degasperi E, Lampertico P, Chow WC, Bertoletti A, Kennedy PT

doi: 10.1016/j.jhep.2025.06.012

Hepatitis

Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta

J Hepatol

Degasperi E, Scholtes C, Testoni B, Renteria SU, Anolli MP, Charre C, Facchetti F, Plissonnier ML, Sambarino D, Perbellini R, Monico S, Callegaro A, García-Pras E, Lens S, Cortese MF, Forns X, Pérez-Del-Pulgar S, Heil M, Levrero M, Zoulim F, Lampertico P

doi: 10.1016/j.jhep.2024.11.051

HepatologyFurther Publications

All-cause and cause-specific mortality in patients with chronic hepatitis B and concurrent steatotic liver disease

J Hepatol

Huang SC, Su TH, Tseng TC, Hsu SJ, Hong CM, Lan TY, Liu CH, Yang HC, Liu CJ, Kao JH

doi: 10.1016/j.jhep.2024.12.009

Gastrointestinal Cancer

Circulating Inflammation Biomarkers and the Risk of Esophageal Adenocarcinoma: A Nested Case-control Study in the Department of Defense Serum Repository

Cancer Epidemiol Biomarkers Prev

Omofuma OO, Rusiecki JA, Petrick JL, Falk RT, Wheeler W, Pfeiffer RM, Camargo MC, Cook MB

doi: 10.1158/1055-9965.EPI-24-1544

Related content

EASL 2025 indications revisited: phase-specific outcomes with and without nucleos(t)ide analogue therapy in chronic hepatitis B virus infection

Association of liver related biomarkers with incident cardiovascular disease and all-cause mortality in the Hispanic community health study/study of Latinos (HCHS/SOL), a population-based cohort study

Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologies

Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial

Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study : MASLD, MetALD, and dementia risk

Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phases

Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta

All-cause and cause-specific mortality in patients with chronic hepatitis B and concurrent steatotic liver disease

Circulating Inflammation Biomarkers and the Risk of Esophageal Adenocarcinoma: A Nested Case-control Study in the Department of Defense Serum Repository